← Product Code [SAO](/productcode/SAO) · K262051

# Osteo Signal DX (PROS CXR-08) (K262051)

_Promedius, Inc. · SAO · Nov 13, 2026 · Radiology · SESE_

**Canonical URL:** https://fda.innolitics.com/device/K262051

## Device Facts

- **Applicant:** Promedius, Inc.
- **Product Code:** [SAO](/productcode/SAO.md)
- **Decision Date:** Nov 13, 2026
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 892.1171
- **Device Class:** Class 2
- **Review Panel:** Radiology

## Regulatory Identification

Radiology software for opportunistic evaluation of low bone mineral density. This device is software which opportunistically assesses radiological images to estimate bone mineral density (BMD) intended to assist in a healthcare professional's decision to evaluate patients for possible low BMD within a bone health screening program. The software employs an algorithm that estimates BMD using eligible radiological image data obtained for other clinical purposes.

## Special Controls

In combination with the general controls of the FD&C Act, radiology software for opportunistic evaluation of low bone mineral density is subject to the following special controls:

---

**Source:** [https://fda.innolitics.com/device/K262051](https://fda.innolitics.com/device/K262051)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
